Integrated Filing — IndAS
General information about company
| Scrip Code |
540975 |
| NSE Symbol |
ASTERDM |
| MSEI Symbol |
NOTLISTED |
| ISIN |
INE914M01019 |
| Name of company |
Aster DM Healthcare Limited |
| Type of company |
Main Board |
| Class of security |
Equity |
| Date of start of financial year |
01-04-2025 |
| Date of end of financial year |
31-03-2026 |
| Date of board meeting when results were approved |
30-04-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed
to the exchange |
25-04-2026 |
| Description of presentation currency |
INR |
| Level of rounding used in financial results |
Lakhs |
| Reporting Type |
Quarterly |
| Reporting Quarter |
Fourth quarter |
| Nature of report standalone or consolidated |
Consolidated |
| Whether results are audited or unaudited for the quarter ended |
Audited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended |
Audited |
| Segment Reporting |
Multi segment |
| Description of single segment |
|
| Start date and time of board meeting |
30-04-2026 10:30:00 |
| End date and time of board meeting |
30-04-2026 15:35:00 |
| Whether cash flow statement is applicable on company |
Yes |
| Type of cash flow statement |
Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Declaration of unmodified opinion |
Financial Results Ind-AS
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-01-2026 |
01-04-2025 |
| B |
Date of end of reporting period |
31-03-2026 |
31-03-2026 |
| C |
Whether results are audited or unaudited |
Audited |
Audited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
| 1 |
Income |
|
Revenue from operations |
1,18,238.00 |
4,64,322.00 |
|
Other income |
3,620.00 |
12,560.00 |
|
Total income |
1,21,858.00 |
4,76,882.00 |
| 2 |
Expenses |
| (a) |
Cost of materials consumed |
0.00 |
0.00 |
| (b) |
Purchases of stock-in-trade |
25,897.00 |
1,04,761.00 |
| (c) |
Changes in inventories of finished goods,
work-in-progress and stock-in-trade |
419.00 |
118.00 |
| (d) |
Employee benefit expense |
21,999.00 |
84,809.00 |
| (e) |
Finance costs |
2,999.00 |
12,298.00 |
| (f) |
Depreciation, depletion and amortisation expense
|
6,724.00 |
26,425.00 |
| (f) |
Other Expenses |
| 1 |
Professional fees to consultant doctors |
26,466.00 |
1,03,187.00 |
| 2 |
Laboratory outsourcing charges |
535.00 |
2,752.00 |
| 3 |
Other expenses |
19,664.00 |
78,592.00 |
| 4 |
0 |
0.00 |
0.00 |
| 5 |
0 |
0.00 |
0.00 |
| 6 |
0 |
0.00 |
0.00 |
| 7 |
0 |
0.00 |
0.00 |
| 8 |
0 |
0.00 |
0.00 |
| 9 |
0 |
0.00 |
0.00 |
| 10 |
0 |
0.00 |
0.00 |
|
Total other expenses |
46,665.00 |
1,84,531.00 |
|
Total expenses |
1,04,703.00 |
4,12,942.00 |
| 3 |
Total profit before exceptional items and tax |
17,155.00 |
63,940.00 |
| 4 |
Exceptional items |
33.00 |
(3,271.00) |
| 5 |
Total profit before tax |
17,188.00 |
60,669.00 |
| 6 |
Tax expense |
|
| 7 |
Current tax |
3,637.00 |
18,603.00 |
| 8 |
Deferred tax |
(2,660.00) |
(4,344.00) |
| 9 |
Total tax expenses |
977.00 |
14,259.00 |
| 10 |
Net movement in regulatory deferral account balances related to profit or loss and
the related deferred tax movement |
0.00 |
0.00 |
| 11 |
Net Profit Loss for the period from
continuing operations |
16,211.00 |
46,410.00 |
| 12 |
Profit (loss) from discontinued operations before tax |
0.00 |
0.00 |
| 13 |
Tax expense of discontinued operations |
0.00 |
0.00 |
| 14 |
Net profit (loss) from discontinued
operation after tax |
0.00 |
0.00 |
| 15 |
Share of profit (loss) of associates and joint ventures accounted for using equity
method |
(853.00) |
(3,700.00) |
| 16 |
Total profit (loss) for period |
15,358.00 |
42,710.00 |
| 17 |
Other comprehensive income net of taxes |
260.00 |
36.00 |
| 18 |
Total Comprehensive Income for the period |
15,618.00 |
42,746.00 |
| 19 |
Total profit or loss, attributable to
|
|
|
|
Profit or loss, attributable to owners of parent |
14,017.00 |
38,814.00 |
|
Total profit or loss, attributable to non-controlling interests |
1,341.00 |
3,896.00 |
| 20 |
Total Comprehensive income for the period attributable to |
|
|
|
Comprehensive income for the period attributable to owners of parent |
14,256.00 |
38,852.00 |
|
Total comprehensive income for the period attributable to owners of parent non-controlling
interests |
1,362.00 |
3,894.00 |
| 21 |
Details of equity share capital |
|
|
Paid-up equity share capital |
51,813.00 |
51,813.00 |
|
Face value of equity share capital |
10 |
10 |
| 27 |
Details of debt securities |
|
| 22 |
Reserves excluding revaluation reserve |
|
3,70,917.00 |
| 23 |
Earnings per share |
|
| i |
Earnings per equity share for continuing operations |
|
|
Basic earnings (loss) per share from continuing operations |
2.72 |
7.53 |
|
Diluted earnings (loss) per share from continuing operations |
2.71 |
7.52 |
| ii |
Earnings per equity share for discontinued operations |
|
|
Basic earnings (loss) per share from discontinued operations |
0 |
0 |
|
Diluted earnings (loss) per share from discontinued operations |
0 |
0 |
| ii |
Earnings per equity share |
|
|
Basic earnings (loss) per share from continuing
and discontinued operations |
2.72 |
7.53 |
|
Diluted earnings (loss) per share from
continuing and discontinued operations |
2.71 |
7.52 |
| 24 |
Debt equity ratio |
|
|
| 25 |
Debt service coverage ratio |
|
|
| 26 |
Interest service coverage ratio |
|
|
| 27 |
Disclosure of notes on financial results |
|
Remarks
Statement of Asset and Liabilities
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-04-2025 |
| Date of end of reporting period |
31-03-2026 |
| Whether results are audited or unaudited |
Audited |
| Nature of report standalone or consolidated |
Consolidated |
|
Assets |
| 1 |
Non-current assets |
|
Property, plant and equipment |
2,61,874.00 |
|
Capital work-in-progress |
41,259.00 |
|
Investment property |
0.00 |
|
Goodwill |
26,412.00 |
|
Other intangible assets |
1,925.00 |
|
Intangible assets under development |
702.00 |
|
Biological assets other than bearer plants |
0.00 |
|
Investments accounted for using equity method |
19,390.00 |
|
Non-current financial assets |
|
|
Non-current investments |
97,125.00 |
|
Trade receivables, non-current |
0.00 |
|
Loans, non-current |
125.00 |
|
Other non-current financial assets |
|
| 1 |
Other non-current financial assets |
13,627.00 |
| 2 |
0 |
0.00 |
| 3 |
0 |
0.00 |
| 4 |
0 |
0.00 |
| 5 |
0 |
0.00 |
| 6 |
0 |
0.00 |
|
Total of other non-current financial assets |
13,627.00 |
|
Total non-current financial assets |
1,10,877.00 |
|
Deferred tax assets (net) |
3,620.00 |
|
Other non-current assets |
|
| 1 |
Other non-current assets |
9,024.00 |
| 2 |
Income tax assets |
7,380.00 |
| 3 |
Right-of-use assets |
1,33,954.00 |
| 4 |
0 |
0.00 |
| 5 |
0 |
0.00 |
|
Total of other non-current assets |
1,50,358.00 |
|
Total non-current assets |
6,16,417.00 |
| 2 |
Current assets |
|
|
Inventories |
9,116.00 |
|
Current financial asset |
|
|
Current investments |
141.00 |
|
Trade receivables, current |
30,723.00 |
|
Cash and cash equivalents |
22,807.00 |
|
Bank balance other than cash and cash equivalents |
1,09,729.00 |
|
Loans, current |
0.00 |
|
Other current financial assets |
|
|
Total of other current financial assets |
15,860.00 |
|
Total current financial assets |
1,79,260.00 |
|
Current tax assets (net) |
0.00 |
|
Other current assets |
|
| 1 |
Other current assets |
6,403.00 |
| 2 |
0 |
0.00 |
| 3 |
0 |
0.00 |
| 4 |
0 |
0.00 |
| 5 |
0 |
0.00 |
|
Total of other current assets |
6,403.00 |
|
Total current assets |
1,94,779.00 |
| 3 |
Non-current assets classified as held for sale |
0.00 |
| 4 |
Regulatory deferral account debit balances and related deferred tax Assets |
0.00 |
|
Total assets |
8,11,196.00 |
|
Equity and liabilities |
|
| 1 |
Equity |
|
|
Equity attributable to owners of parent |
|
|
Equity share capital |
51,813.00 |
|
Other equity |
4,05,773.00 |
|
Total equity attributable to owners of parent |
4,57,586.00 |
|
Non controlling interest |
25,784.00 |
|
Total equity |
4,83,370.00 |
| 2 |
Liabilities |
|
|
Non-current liabilities |
|
|
Non-current financial liabilities |
|
|
Borrowings, non-current |
55,844.00 |
|
Trade payables, non-current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
0.00 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
0.00 |
|
Total Trade payable |
0.00 |
|
Other non-current financial liabilities |
|
| 1 |
Lease liabilities |
1,48,883.00 |
| 2 |
Other non current financial liabilities |
378.00 |
| 3 |
0 |
0.00 |
| 4 |
0 |
0.00 |
| 5 |
0 |
0.00 |
|
Total of other non-current financial liabilities |
1,49,261.00 |
|
Total non-current financial liabilities |
2,05,105.00 |
|
Provisions, non-current |
5,343.00 |
|
Deferred tax liabilities (net) |
13,282.00 |
|
Deferred government grants, Non-current |
6,180.00 |
|
Other non-current liabilities |
|
| 1 |
0 |
0.00 |
| 2 |
0 |
0.00 |
| 3 |
0 |
0.00 |
| 4 |
0 |
0.00 |
| 5 |
0 |
0.00 |
|
Total of other non-current liabilities |
0.00 |
|
Total non-current liabilities |
2,29,910.00 |
|
Current liabilities |
|
|
Current financial liabilities |
|
|
Borrowings, current |
14,274.00 |
|
Trade payables, current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
4,442.00 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
43,709.00 |
|
Total Trade payable |
48,151.00 |
|
Other current financial liabilities |
|
| 1 |
Lease liabilities |
2,965.00 |
| 2 |
Other current financial liabilities |
8,996.00 |
| 3 |
0 |
0.00 |
| 4 |
0 |
0.00 |
| 5 |
0 |
0.00 |
|
Total of other current financial liabilities |
11,961.00 |
|
Total current financial liabilities |
74,386.00 |
|
Other current liabilities |
21,386.00 |
| 1 |
Other current liabilities |
21,386.00 |
| 2 |
0 |
0.00 |
| 3 |
0 |
0.00 |
| 4 |
0 |
0.00 |
| 5 |
0 |
0.00 |
|
Total of other current liabilities |
21,386.00 |
|
Provisions, current |
1,206.00 |
|
Current tax liabilities (Net) |
1.00 |
|
Deferred government grants, Current |
937.00 |
|
Total current liabilities |
97,916.00 |
| 3 |
Liabilities directly associated with assets in disposal group classified as held for sale |
0.00 |
| 4 |
Regulatory deferral account credit balances and related deferred tax liability |
0.00 |
|
Total liabilities |
3,27,826.00 |
|
Total equity and liabilites |
8,11,196.00 |
|
Disclosure of notes on assets and liabilities |
|
Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Amount in (Lakhs)
| Particulars |
3 months/ 6 month ended (dd-mm-yyyy) |
Year to date figures for current period
ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-01-2026 |
01-04-2025 |
| Date of end of reporting
period |
31-03-2026 |
31-03-2026 |
| Whether results are audited
or unaudited |
Audited |
Audited |
| Nature of report standalone or
consolidated |
Consolidated |
Consolidated |
| 1 |
Segment Revenue (Income) |
|
(net sale/income from each segment should
be disclosed) |
| 1 |
Hospitals & Clinics |
1,15,256.00 |
4,50,639.00 |
| 2 |
Labs |
3,851.00 |
15,350.00 |
| 3 |
Wholesale Pharmacies |
1,977.00 |
10,832.00 |
| 4 |
Others |
0.00517 |
1,479.00 |
| 5 |
0 |
0.00 |
0.00 |
| 6 |
0 |
0.00 |
0.00 |
| 7 |
0 |
0.00 |
0.00 |
| 8 |
0 |
0.00 |
0.00 |
| 9 |
0 |
0.00 |
0.00 |
| 10 |
0 |
0.00 |
0.00 |
| 11 |
0 |
0.00 |
0.00 |
| 12 |
0 |
0.00 |
0.00 |
| 13 |
0 |
0.00 |
0.00 |
| 14 |
0 |
0.00 |
0.00 |
| 15 |
0 |
0.00 |
0.00 |
|
Total Segment Revenue |
1,21,601.00 |
4,78,300.00 |
|
Less: Inter segment revenue |
3,363.00 |
13,978.00 |
|
Revenue from operations |
1,18,238.00 |
4,64,322.00 |
| 2 |
Segment Result |
|
Profit (+) / Loss (-) before tax and
interest from each segment |
| 1 |
Hospitals & Clinics |
20,681.00 |
78,042.00 |
| 2 |
Labs |
398.00 |
1,484.00 |
| 3 |
Wholesale Pharmacies |
(36.00) |
79.00 |
| 4 |
Others |
(109.00) |
(1,700.00) |
| 5 |
0 |
0.00 |
0.00 |
| 6 |
0 |
0.00 |
0.00 |
| 7 |
0 |
0.00 |
0.00 |
| 8 |
0 |
0.00 |
0.00 |
| 9 |
0 |
0.00 |
0.00 |
| 10 |
0 |
0.00 |
0.00 |
| 11 |
0 |
0.00 |
0.00 |
| 12 |
0 |
0.00 |
0.00 |
| 13 |
0 |
0.00 |
0.00 |
| 14 |
0 |
0.00 |
0.00 |
| 15 |
0 |
0.00 |
0.00 |
|
Total Profit before tax |
20,934.00 |
77,905.00 |
|
i. Finance cost |
2,999.00 |
12,298.00 |
|
ii. Other Unallocable Expenditure net off Unallocable income |
1,600.00 |
8,638.00 |
|
Profit before tax |
16,335.00 |
56,969.00 |
| 3 |
(Segment Asset - Segment Liabilities)
|
|
Segment Asset |
| 1 |
Hospitals & Clinics |
6,71,199.00 |
6,71,199.00 |
| 2 |
Labs |
8,334.00 |
8,334.00 |
| 3 |
Wholesale Pharmacies |
5,534.00 |
5,534.00 |
| 4 |
Others |
2,662.00 |
2,662.00 |
| 5 |
0 |
0.00 |
0.00 |
| 6 |
0 |
0.00 |
0.00 |
| 7 |
0 |
0.00 |
0.00 |
| 8 |
0 |
0.00 |
0.00 |
| 9 |
0 |
0.00 |
0.00 |
| 10 |
0 |
0.00 |
0.00 |
| 11 |
0 |
0.00 |
0.00 |
| 12 |
0 |
0.00 |
0.00 |
| 13 |
0 |
0.00 |
0.00 |
| 14 |
0 |
0.00 |
0.00 |
| 15 |
0 |
0.00 |
0.00 |
|
Total Segment Asset |
6,87,729.00 |
6,87,729.00 |
|
Un-allocable Assets |
1,23,467.00 |
1,23,467.00 |
|
Net Segment Asset |
8,11,196.00 |
8,11,196.00 |
| 4 |
Segment Liabilities |
|
Segment Liabilities |
| 1 |
Hospitals & Clinics |
2,93,745.00 |
2,93,745.00 |
| 2 |
Labs |
5,951.00 |
5,951.00 |
| 3 |
Wholesale Pharmacies |
875.00 |
875.00 |
| 4 |
Others |
0.00 |
0.00 |
| 5 |
0 |
0.00 |
0.00 |
| 6 |
0 |
0.00 |
0.00 |
| 7 |
0 |
0.00 |
0.00 |
| 8 |
0 |
0.00 |
0.00 |
| 9 |
0 |
0.00 |
0.00 |
| 10 |
0 |
0.00 |
0.00 |
| 11 |
0 |
0.00 |
0.00 |
| 12 |
0 |
0.00 |
0.00 |
| 13 |
0 |
0.00 |
0.00 |
| 14 |
0 |
0.00 |
0.00 |
| 15 |
0 |
0.00 |
0.00 |
|
Total Segment Liabilities |
3,00,571.00 |
3,00,571.00 |
|
Un-allocable Liabilities |
27,255.00 |
27,255.00 |
|
Net Segment Liabilities |
3,27,826.00 |
3,27,826.00 |
|
Disclosure of notes on segments |
|
Other Comprehensive Income
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-01-2026 |
01-04-2025 |
| B |
Date of end of reporting period |
31-03-2026 |
31-03-2026 |
| C |
Whether results are audited or unaudited |
Audited |
Audited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
|
Other comprehensive income [Abstract] |
|
| 1 |
Amount of items that will not be reclassified to profit and loss |
|
| 1 |
Remeasurement of net defined benefit liability |
272.00 |
(22.00) |
|
Total Amount of items that will not be reclassified to profit and loss |
272.00 |
(22.00) |
| 2 |
Income tax relating to items that will not be reclassified to profit or loss |
65.00 |
(5.00) |
| 3 |
Amount of items that will be reclassified to profit and loss |
|
| 1 |
Exchange difference in translating financial statements of foreign operations |
73.00 |
73.00 |
|
Total Amount of items that will be reclassified to profit and loss |
73.00 |
73.00 |
| 4 |
Income tax relating to items that will be reclassified to profit or loss |
20.00 |
20.00 |
| 5 |
Total Other comprehensive income |
260.00 |
36.00 |
Cash flow statement, indirect
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-04-2025 |
| B |
Date of end of reporting period |
31-03-2026 |
| C |
Whether results are audited or unaudited |
Audited |
| D |
Nature of report standalone or consolidated |
Consolidated |
|
Statement of cash flows |
|
|
Cash flows from used in operating
activities |
|
|
Profit before tax |
60,669.00 |
|
Adjustments for reconcile profit (loss) |
|
|
Adjustments for finance costs |
12,298.00 |
|
Adjustments for decrease (increase) in inventories |
119.00 |
|
Adjustments for decrease (increase) in trade receivables, current |
(6,174.00) |
|
Adjustments for decrease (increase) in trade receivables, non-current
|
0.00 |
|
Adjustments for decrease (increase) in other current assets |
0.00 |
|
Adjustments for decrease (increase) in other non-current assets |
0.00 |
|
Adjustments for other financial assets, non-current |
(9,602.00) |
|
Adjustments for other financial assets, current |
0.00 |
|
Adjustments for other bank balances |
0.00 |
|
Adjustments for increase (decrease) in trade payables, current |
0.00 |
|
Adjustments for increase (decrease) in trade payables, non-current |
0.00 |
|
Adjustments for increase (decrease) in other current liabilities |
0.00 |
|
Adjustments for increase (decrease) in other non-current liabilities
|
0.00 |
|
Adjustments for depreciation and amortisation expense |
26,425.00 |
|
Adjustments for impairment loss reversal of impairment loss recognised
in profit or loss |
0.00 |
|
Adjustments for provisions, current |
0.00 |
|
Adjustments for provisions, non-current |
0.00 |
|
Adjustments for other financial liabilities, current |
6,148.00 |
|
Adjustments for other financial liabilities, non-current |
0.00 |
|
Adjustments for unrealised foreign exchange losses gains |
0.00 |
|
Adjustments for dividend income |
0.00 |
|
Adjustments for interest income |
10,327.00 |
|
Adjustments for share-based payments |
0.00 |
|
Adjustments for fair value losses (gains) |
(192.00) |
|
Adjustments for undistributed profits of associates |
0.00 |
|
Other adjustments for which cash effects are investing or financing
cash flow |
187.00 |
|
Other adjustments to reconcile profit (loss) |
0.00 |
|
Other adjustments for non-cash items |
2,063.00 |
|
Share of profit and loss from partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Total adjustments for reconcile
profit (loss) |
20,945.00 |
|
Net cash flows from (used in)
operations |
81,614.00 |
|
Dividends received |
0.00 |
|
Interest paid |
0.00 |
|
Interest received |
0.00 |
|
Income taxes paid (refund) |
16,022.00 |
|
Other inflows (outflows) of cash |
0.00 |
|
Net cash flows from (used in)
operating activities |
65,592.00 |
|
Cash flows from used in
investing activities |
|
|
Cash flows from losing control of subsidiaries or other businesses |
0.00 |
|
Cash flows used in obtaining control of subsidiaries or other businesses |
0.00 |
|
Other cash receipts from sales of equity or debt instruments of other
entities |
0.00 |
|
Other cash payments to acquire equity or debt instruments of other entities
|
307.00 |
|
Other cash receipts from sales of interests in joint ventures |
0.00 |
|
Other cash payments to acquire interests in joint ventures |
0.00 |
|
Cash receipts from share of profits of partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Cash payment for investment in partnership firm or association of persons or
limited liability partnerships |
0.00 |
|
Proceeds from sales of property, plant and equipment |
70.00 |
|
Purchase of property, plant and equipment |
46,908.00 |
|
Proceeds from sales of investment property |
0.00 |
|
Purchase of investment property |
0.00 |
|
Proceeds from sales of intangible assets |
0.00 |
|
Purchase of intangible assets |
844.00 |
|
Proceeds from sales of intangible assets under development |
0.00 |
|
Purchase of intangible assets under development |
0.00 |
|
Proceeds from sales of goodwill |
0.00 |
|
Purchase of goodwill |
0.00 |
|
Proceeds from biological assets other than bearer plants |
0.00 |
|
Purchase of biological assets other than bearer plants |
0.00 |
|
Proceeds from government grants |
0.00 |
|
Proceeds from sales of other long-term assets |
0.00 |
|
Purchase of other long-term assets |
0.00 |
|
Cash advances and loans made to other parties |
0.00 |
|
Cash receipts from repayment of advances and loans made to other parties |
0.00 |
|
Cash payments for future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Cash receipts from future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Dividends received |
0.00 |
|
Interest received |
6,776.00 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
12,392.00 |
|
Net cash flows from (used in)
investing activities |
(28,821.00) |
|
Cash flows from used in
financing activities |
|
|
Proceeds from changes in ownership interests in subsidiaries |
0.00 |
|
Payments from changes in ownership interests in subsidiaries |
8,194.00 |
|
Proceeds from issuing shares |
250.00 |
|
Proceeds from issuing other equity instruments |
0.00 |
|
Payments to acquire or redeem entity's shares |
0.00 |
|
Payments of other equity instruments |
0.00 |
|
Proceeds from exercise of stock options |
0.00 |
|
Proceeds from issuing debentures notes bonds etc |
0.00 |
|
Proceeds from borrowings |
16,497.00 |
|
Repayments of borrowings |
15,039.00 |
|
Payments of lease liabilities |
13,117.00 |
|
Dividends paid |
5,513.00 |
|
Interest paid |
5,318.00 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
0.00 |
|
Net cash flows from (used in)
financing activities |
(30,434.00) |
|
Net increase (decrease) in cash
and cash equivalents before effect of exchange rate changes |
6,337.00 |
|
Effect of exchange rate changes
on cash and cash equivalents |
|
|
Effect of exchange rate changes on cash and cash equivalents |
11.00 |
|
Net increase (decrease) in cash
and cash equivalents |
6,348.00 |
|
Cash and cash equivalents cash flow statement at beginning of period
|
16,459.00 |
|
Cash and cash equivalents cash
flow statement at end of period |
22,807.00 |
Details of Impact of Audit Qualification
Amount in (Lakhs)
| Whether results are audited or unaudited |
Audited |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Declaration of unmodified opinion |
| Auditor's opinion |
|
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015:
The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified
opinion for the period on Standalone results |
Yes |
| Sr No. |
Audit firm's name |
Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI |
Certificate valid upto |
| 1 |
M/S Deloitte Haskins & Sells |
Yes |
30-04-2028 |